Primary Driver in the Dukoral Market 2025: Rising Cholera Incidence Fuels Demand

January 25, 2025 04:09 AM AEDT | By EIN Presswire
 Primary Driver in the Dukoral Market 2025: Rising Cholera Incidence Fuels Demand
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, January 25, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Is the Dukoral Market Set to Witness Substantial Growth?

The Dukoral global market, an oral cholera vaccine, has shown notable expansion in recent years. With an increase in Cholera cases globally fueled by poor sanitation, contaminated water, and climate change, demand for effective oral vaccines like Dukoral is rising. The Dukoral market size, which was calculated at $XX million in 2024, is projected to grow at a compound annual growth rate CAGR of XX% to $XX million by 2025.

This growth has been possible due to increasing government investments in vaccination programs and public health initiatives, rising awareness of cholera prevention among travelers and local populations, and an elevated demand for oral cholera vaccines. The market has also benefitted from the growing prevalence of antibiotic-resistant infections, increased awareness of waterborne diseases, and recurrent cholera outbreaks.

In the forecast period up until 2029, the Dukoral market size is expected to continue its steady climb, growing with a projected compound annual growth rate CAGR of XX% to $XX. Factors credited with this anticipated growth include escalating government initiatives to bolster vaccination programs, an amplified focus on preventive healthcare, rising awareness of the necessity of cholera vaccination, and persistent demand for oral vaccines.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20040&type=smp

Technological advancements and innovative manufacturing techniques are set to revolutionize the Dukoral market. Players in this market are advancing oral vaccine formulations, enhancing the stability and shelf life of vaccines allowing for better distribution in regions with limited healthcare infrastructure. New vaccine formulations are also in the pipeline, thanks to innovations in vaccine research and development.

What Drives The Dukoral Market Growth?
The most significant growth is expected due to the rising incidence of cholera cases globally. Cholera, an acute diarrheal disease caused by ingestion of food or water infected with Vibrio cholerae, leads to severe dehydration and, in severe cases, death. The vaccine, Dukoral, decreases cholera cases by creating immunity against Vibrio cholerae bacteria and its toxin, hence reducing the chance of infection. Recent reports from the World Health Organization WHO indicate an upward trend in cholera cases. In 2023, the cases increased by 13%, with a disturbing 71% surge in fatalities compared to 2022. Therefore, this rising incidence is projected to fuel the growth of the Dukoral market.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/dukoral-global-market-report

Who Are The Key Players In The Dukoral Market?

Currently, major companies dominating the Dukoral market include Valneva SE, a global leader in developing vaccines for infectious diseases.

What Are The Emerging Trends In The Dukoral Market?

Emerging trends in the Dukoral market revolve around low-cost oral cholera vaccines. This notable drive to bring affordability and easy administration to resource-limited regions is revolutionizing the market landscape.

How Is The Dukoral Market Segmented?

The Dukoral market encapsulates a wide range of segments:
1 By Indication: Cholera, Traveler's Diarrhea
2 By Distribution Channel: Pharmacies, Travel Clinics, Healthcare Providers
3 By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Regional Analysis Of Dukoral Market:

In 2024, the Dukoral market found its largest consumer base in the Asia-Pacific region. The regions evaluated in the Dukoral market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Browse for more similar reports-
Implantable Drug Delivery Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report
Intravenous Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Implantable Infusion Pumps Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report

About The Business Research Company
The Business Research Company excels in company, market, and consumer research. With over 15000+ reports from 27 industries covering 60+ geographies, the firm has earned a reputation for delivering comprehensive, data-rich research and insights. Equipped with 1,500,000 datasets, a thorough secondary research approach, and unique insights from industry leaders, you can access the information you need to stay ahead of the competition.

Contact us at:
The Business Research Company: Email [email protected]
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.